156 related articles for article (PubMed ID: 33501731)
1. Photobiomodulation therapy for thrombocytopenia by upregulating thrombopoietin expression via the ROS-dependent Src/ERK/STAT3 signaling pathway.
Wang Q; Chang H; Shen Q; Li Y; Xing D
J Thromb Haemost; 2021 Aug; 19(8):2029-2043. PubMed ID: 33501731
[TBL] [Abstract][Full Text] [Related]
2. Regulation of platelet lifespan in the presence and absence of thrombopoietin signaling.
Lebois M; Dowling MR; Gangatirkar P; Hodgkin PD; Kile BT; Alexander WS; Josefsson EC
J Thromb Haemost; 2016 Sep; 14(9):1882-7. PubMed ID: 27344013
[TBL] [Abstract][Full Text] [Related]
3. Targeting a thrombopoietin-independent strategy in the discovery of a novel inducer of megakaryocytopoiesis, DMAG, for the treatment of thrombocytopenia.
Wang L; Liu S; Luo J; Mo Q; Ran M; Zhang T; Li X; Zou W; Mei Q; Chen J; Yang J; Zeng J; Huang F; Wu A; Zhang C; Wu J
Haematologica; 2023 May; 108(5):1394-1411. PubMed ID: 36546424
[TBL] [Abstract][Full Text] [Related]
4.
Chen X; Wang C; Sun N; Pan S; Li R; Li X; Zhao J; Tong H; Tang Y; Han J; Qiao J; Qiu H; Wang H; Yang J; Ikezoe T
Theranostics; 2021; 11(10):4655-4671. PubMed ID: 33754019
[No Abstract] [Full Text] [Related]
5. Thrombopoietin receptor agonist antibody for treating chemotherapy-induced thrombocytopenia.
Shin J; Kim MJ; Quan X; Kim JW; Lee S; Park S; Jeong JY; Yea K
BMC Cancer; 2023 May; 23(1):490. PubMed ID: 37259024
[TBL] [Abstract][Full Text] [Related]
6. Novel chemical-structure TPOR agonist, TMEA, promotes megakaryocytes differentiation and thrombopoiesis via mTOR and ERK signalings.
Jiang X; Sun Y; Yang S; Wu Y; Wang L; Zou W; Jiang N; Chen J; Han Y; Huang C; Wu A; Zhang C; Wu J
Phytomedicine; 2023 Feb; 110():154637. PubMed ID: 36610353
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietin is a major regulator of thrombopoiesis in thrombopoietin-dependent and -independent contexts.
Hacein-Bey-Abina S; Estienne M; Bessoles S; Echchakir H; Pederzoli-Ribeil M; Chiron A; Aldaz-Carroll L; Leducq V; Zhang Y; Souyri M; Louache F; Abina AM
Exp Hematol; 2020 Aug; 88():15-27. PubMed ID: 32721504
[TBL] [Abstract][Full Text] [Related]
8. AKR-501 (YM477) in combination with thrombopoietin enhances human megakaryocytopoiesis.
Fukushima-Shintani M; Suzuki K; Iwatsuki Y; Abe M; Sugasawa K; Hirayama F; Kawasaki T
Exp Hematol; 2008 Oct; 36(10):1337-42. PubMed ID: 18619724
[TBL] [Abstract][Full Text] [Related]
9. Human adipose tissue-derived stromal cells can differentiate into megakaryocytes and platelets by secreting endogenous thrombopoietin.
Ono-Uruga Y; Tozawa K; Horiuchi T; Murata M; Okamoto S; Ikeda Y; Suda T; Matsubara Y
J Thromb Haemost; 2016 Jun; 14(6):1285-97. PubMed ID: 26990635
[TBL] [Abstract][Full Text] [Related]
10. Humoral control of thrombopoiesis.
Levin J; Evatt BL
Blood Cells; 1979 Mar; 5(1):105-21. PubMed ID: 555683
[TBL] [Abstract][Full Text] [Related]
11. Discovery of a novel megakaryopoiesis enhancer, ingenol, promoting thrombopoiesis through PI3K-Akt signaling independent of thrombopoietin.
Wang L; Zhang T; Liu S; Mo Q; Jiang N; Chen Q; Yang J; Han YW; Chen JP; Huang FH; Li H; Zhou J; Luo JS; Wu JM
Pharmacol Res; 2022 Mar; 177():106096. PubMed ID: 35077844
[TBL] [Abstract][Full Text] [Related]
12. Efficiently Restored Thrombopoietin Production by Ashwell-Morell Receptor and IL-6R Induced Janus Kinase 2/Signal Transducer and Activator of Transcription Signaling Early After Partial Hepatectomy.
Reusswig F; Fazel Modares N; Brechtenkamp M; Wienands L; Krüger I; Behnke K; Lee-Sundlov MM; Herebian D; Scheller J; Hoffmeister KM; Häussinger D; Elvers M
Hepatology; 2021 Jul; 74(1):411-427. PubMed ID: 33369745
[TBL] [Abstract][Full Text] [Related]
13. Milestones in understanding platelet production: a historical overview.
Kuter DJ
Br J Haematol; 2014 Apr; 165(2):248-58. PubMed ID: 24528208
[TBL] [Abstract][Full Text] [Related]
14. The biology of thrombopoietin and thrombopoietin receptor agonists.
Kuter DJ
Int J Hematol; 2013 Jul; 98(1):10-23. PubMed ID: 23821332
[TBL] [Abstract][Full Text] [Related]
15. Thrombocytopenia in c-mpl-deficient mice.
Gurney AL; Carver-Moore K; de Sauvage FJ; Moore MW
Science; 1994 Sep; 265(5177):1445-7. PubMed ID: 8073287
[TBL] [Abstract][Full Text] [Related]
16. The pathophysiology of ITP revisited: ineffective thrombopoiesis and the emerging role of thrombopoietin receptor agonists in the management of chronic immune thrombocytopenic purpura.
Gernsheimer TB
Hematology Am Soc Hematol Educ Program; 2008; ():219-26. PubMed ID: 19074086
[TBL] [Abstract][Full Text] [Related]
17. Novel mechanisms of platelet clearance and thrombopoietin regulation.
Grozovsky R; Giannini S; Falet H; Hoffmeister KM
Curr Opin Hematol; 2015 Sep; 22(5):445-51. PubMed ID: 26154508
[TBL] [Abstract][Full Text] [Related]
18. Advances in megakaryocytopoiesis and thrombopoiesis: from bench to bedside.
Deutsch VR; Tomer A
Br J Haematol; 2013 Jun; 161(6):778-93. PubMed ID: 23594368
[TBL] [Abstract][Full Text] [Related]
19. Activation of toll-like receptors 2 and 4 on CD34
D'Atri LP; Rodríguez CS; Miguel CP; Pozner RG; Ortiz Wilczyñski JM; Negrotto S; Carrera-Silva EA; Heller PG; Schattner M
J Thromb Haemost; 2019 Dec; 17(12):2196-2210. PubMed ID: 31397069
[TBL] [Abstract][Full Text] [Related]
20. Thrombopoietin has a primary role in the regulation of platelet production in preterm babies.
Watts TL; Murray NA; Roberts IA
Pediatr Res; 1999 Jul; 46(1):28-32. PubMed ID: 10400130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
